Septic Arthritis Market Research Report - Forecast till 2030

Septic Arthritis Market Research Report Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) - Forecast till 2030

ID: MRFR/Pharma/3183-HCR | 110 Pages | Author: Rahul Gotadki | October 2023         

Septic Arthritis Market Speak to Analyst Request a Free Sample

Market Synopsis of Septic Arthritis Market


The Septic Arthritis Market is anticipated to reach USD 69,448.42 Million by 2030 at 2.10% CAGR during the forecast period 2022-2030.Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.


The septic arthritis market is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the septic arthritis market.


Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the septic arthritis market. Fierce competition among key market players acts as a barrier for the new entrants in the septic arthritis market.


Segments    


The septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.


On the basis of diagnosis, septic arthritis market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan.


On the basis of treatment, the septic arthritis market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy.


On the basis of indication, the septic arthritis market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others.


On the basis of end user, the septic arthritis market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.


FIGURE 1: Global Septic Arthritis Market by Region, 2016 (%) Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Research Methodology Global Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation Regional Analysis of theSeptic Arthritis Market        


America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.


Europe is the second largest septic arthritis market owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the septic arthritis market growth.


The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.


Key Players in the Septic Arthritis Market    


Some of the key players in the septic arthritis market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.).


Intended Audience



  • Arthritis Drug Manufacturers

  • Arthritis Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 



Report Scope:

Report Attribute/Metric Details
聽聽Market Size 聽聽2030: USD 69,448.42 Million
聽聽CAGR 聽聽2.10% (2022-2030)
聽聽Base Year 聽聽2021
聽聽Forecast Period 聽聽2022-2030
聽聽Historical Data 聽聽2020
聽聽Forecast Units 聽聽Value (USD Million)
聽聽Report Coverage 聽聽Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
聽聽Segments Covered 聽聽Diagnosis, Treatment, Indication, and End user
聽聽Geographies Covered 聽聽North America, Europe, Asia-Pacific, and Rest of the World (RoW)
聽聽Key Vendors 聽聽Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.)
聽聽Key Market Opportunities 聽聽New product launches and R&D Amongst major key Players
聽聽Key Market Drivers 路聽 Increasing prevalence of chronic diseases 路聽 Availability of cost effective treatment 路聽 Extensive research and development activities in internal medicine 路聽 Increasing demand for the new drugs for the treatment of septic arthritis


Frequently Asked Questions (FAQ) :

The septic arthritis market CAGR would be 2.10% during the forecast period.

The septic arthritis market report has joint fluid analysis, blood tests, imaging, and others as a part of diagnostic segmentation.

The septic arthritis market report includes treatments like antibiotics, aspiration of the joint, surgery, and others.

The Americas would lead the septic arthritis market.

The APAC region would be the fastest-growing septic arthritis market.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players鈥 financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid